Oncotarget

Vol 12, No 9

April 27, 2021

View Archive »

Order a Reprint

About The Cover

The cover for issue 9 of Oncotarget features Figure 6, "Identification of potential regulators of the selective alt-NHEJ inhibition of mibefradil," by Paradkar, et al.

Table of Contents

Editorial

Is there a role for CDK 4/6 inhibitors in breast cancer brain metastases?

Is there a role for CDK 4/6 inhibitors in breast cancer brain metastases?

https://doi.org/10.18632/oncotarget.27904

Ilana Schlam,  and Sara M. Tolaney
873-875
PDF  |  How to cite  |  Order a Reprint

Epigenetic effects of pharmacologic ascorbate

Epigenetic effects of pharmacologic ascorbate

https://doi.org/10.18632/oncotarget.27911

Garett J. Steers, Rory S. Carroll, Brianne R. O’Leary,  and Joseph J. Cullen
876-877
PDF  |  How to cite  |  Order a Reprint

Research Papers

Activation of plasmacytoid dendritic cells promotes AML-cell fratricide

Activation of plasmacytoid dendritic cells promotes AML-cell fratricide

https://doi.org/10.18632/oncotarget.27949

Kavin Fatehchand, Payal Mehta, Christopher B. Colvin, Nathaniel J. Buteyn, Ramasamy Santhanam, Giovanna Merchand-Reyes, Hafza Inshaar, Brenda Shen, Xiaokui Mo, Bethany Mundy-Bosse, Susheela Tridandapani,  and Jonathan P. Butchar
878-890
Abstract  |  PDF  |  Full Text  |  How to cite  |  Press Release  |  Order a Reprint

Creation of a new class of radiosensitizers for glioblastoma based on the mibefradil pharmacophore

Creation of a new class of radiosensitizers for glioblastoma based on the mibefradil pharmacophore

https://doi.org/10.18632/oncotarget.27933

Sateja Paradkar, James Herrington, Adam Hendricson, Piyasena Hewawasam, Mark Plummer, Denton Hoyer, Ranjini K. Sundaram, Yulia V. Surovtseva,  and Ranjit S. Bindra
891-906
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite  |  Press Release  |  Podcast  |  Order a Reprint

Piperlongumine promotes death of retinoblastoma cancer cells

Piperlongumine promotes death of retinoblastoma cancer cells

https://doi.org/10.18632/oncotarget.27947

Nathalie Allaman-Pillet,  and Daniel F. Schorderet
907-916
Abstract  |  PDF  |  Full Text  |  How to cite  |  Order a Reprint

A higher De Ritis ratio (AST/ALT) is a risk factor for progression in high-risk non-muscle invasive bladder cancer

A higher De Ritis ratio (AST/ALT) is a risk factor for progression in high-risk non-muscle invasive bladder cancer

https://doi.org/10.18632/oncotarget.27944

Sachi Fukui-Kawaura, Takashi Kawahara, Yushi Araki, Reona Nishimura, Koichi Uemura, Kazuhiro Namura, Nobuhiko Mizuno, Masahiro Yao, Hiroji Uemura,  and Ichiro Ikeda
917-922
Abstract  |  PDF  |  Full Text  |  How to cite  |  Press Release  |  Order a Reprint

Down regulation of lactate dehydrogenase initiates apoptosis in HeLa and MCF-7 cancer cells through increased voltage-dependent anion channel protein and inhibition of BCL2

Down regulation of lactate dehydrogenase initiates apoptosis in HeLa and MCF-7 cancer cells through increased voltage-dependent anion channel protein and inhibition of BCL2

https://doi.org/10.18632/oncotarget.27950

Suhail Al-Salam, Karthishwaran Kandhan,  and Manjusha Sudhadevi
923-935
Abstract  |  PDF  |  Full Text  |  How to cite  |  Press Release  |  Order a Reprint

Reviews

Multigene tests for breast cancer: the physician’s perspective

Multigene tests for breast cancer: the physician’s perspective

https://doi.org/10.18632/oncotarget.27948

Francesco Cognetti, Laura Biganzoli, Sabino De Placido, Lucia del Mastro, Riccardo Masetti, Giuseppe Naso, Giancarlo Pruneri, Donatella Santini, Carlo Alberto Tondini, Corrado Tinterri, Giuseppe Tonini,  and Sandro Barni
936-947
Abstract  |  PDF  |  Full Text  |  How to cite  |  Order a Reprint

Corrections

Correction: Inhibition of thioredoxin 1 leads to apoptosis in drug-resistant multiple myeloma

Correction: Inhibition of thioredoxin 1 leads to apoptosis in drug-resistant multiple myeloma

https://doi.org/10.18632/oncotarget.27444

Prahlad V. Raninga, Giovanna Di Trapani, Slavica Vuckovic, Maneet Bhatia,  and Kathryn F. Tonissen
948-949
Correction  |  PDF  |  How to cite


Copyright © 2021 Impact Journals, LLC
Impact Journals is a registered trademark of Impact Journals, LLC